PECAM-1-dependent heme oxygenase-1 regulation via an Nrf2-mediated pathway in endothelial cells

Summary

The antioxidant enzyme heme oxygenase (HO)-1, which catalyses the first and rate-limiting step of heme degradation, has major anti-inflammatory and immunomodulatory effects via its cell-type-specific functions in the endothelium. In the current study, we investigated whether the key endothelial adhesion and signalling receptor PECAM-1 (CD31) might be involved in the regulation of HO-1 gene expression in human endothelial cells (ECs). To this end PECAM-1 expression was down-regulated in human umbilical vein ECs (HUVECs) by an adenoviral vector-based knockdown approach. PECAM-1 knockdown markedly induced HO-1, but not the constitutive HO isoform HO-2. Nuclear translocation of the transcription factor NF-E2-related factor-2 (Nrf2), which is a master regulator of the inducible antioxidant cell response, and intracellular levels of reactive oxygen species (ROS) were increased in PECAM-1-deficient HUVECs, respectively. PECAM-1-dependent HO-1 regulation was also examined in PECAM-1 over-expressing Chinese hamster ovary and murine L-cells. Endogenous HO-1 gene expression and reporter gene activity of transiently transfected luciferase HO-1 promoter constructs with Nrf2 target sequences were decreased in PECAM-1 over-expressing cells. Moreover, a regulatory role of ROS for HO-1 regulation in these cells is demonstrated by studies with the antioxidant N-acetylcysteine and exogenous hydrogenperoxide. Finally, direct interaction of PECAM-1 with a native complex of its binding partner NB1 (CD177) and serine proteinase 3 (PR3) from human neutrophils, markedly induced HO-1 expression in HUVECs. Taken together, we demonstrate a functional link between HO-1 gene expression and PECAM-1 in human ECs, which might play a critical role in the regulation of inflammation.

Keywords

Heme oxygenase-1 - redox signalling - inflammation - endothelial cells - signal transduction

^* Equal contribution of these authors.

• References

• 1 Tenhunen R, Marver HS, Schmid R. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc Natl Acad Sci USA 1968; 61: 748-755.
• 2 Ryter SW, Alam J, Choi AM. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev 2006; 86: 583-650.
• 3 Yachie A, Niida Y, Wada T. et al. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest 1999; 103: 129-135.
• 4 True AL, Olive M, Boehm M. et al. Heme oxygenase-1 deficiency accelerates formation of arterial thrombosis through oxidative damage to the endothelium, which is rescued by inhaled carbon monoxide. Circ Res 2007; 101: 893-901.
• 5 Poss KD, Tonegawa S. Reduced stress defense in heme oxygenase 1-deficient cells. Proc Natl Acad Sci USA 1997; 94: 10925-10930.
• 6 Balla J, Jacob HS, Balla G. et al. Endothelial-cell heme uptake from heme proteins: induction of sensitisation and desensitisation to oxidant damage. Proc Natl Acad Sci USA 1993; 90: 9285-9289.
• 7 Immenschuh S, Schroder H. Heme oxygenase-1 and cardiovascular disease. Histol Histopathol 2006; 21: 679-685.
• 8 Stocker R, Perrella MA. Heme oxygenase-1: a novel drug target for atherosclerotic diseases?. Circulation 2006; 114: 2178-2189.
• 9 Wu ML, Ho YC, Yet SF. A central role of heme oxygenase-1 in cardiovascular protection. Antioxid Redox Signal 2011; 15: 1835-1846.
• 10 Soares MP, Seldon MP, Gregoire IP. et al. Heme oxygenase-1 modulates the expression of adhesion molecules associated with endothelial cell activation. J Immunol 2004; 172: 3553-3563.
• 11 Choi AM, Alam J. Heme oxygenase-1: function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury. Am J Respir Cell Mol Biol 1996; 15: 9-19.
• 12 Immenschuh S, Ramadori G. Gene regulation of heme oxygenase-1 as a therapeutic target. Biochem Pharmacol 2000; 60: 1121-1128.
• 13 Paine A, Eiz-Vesper B, Blasczyk R. et al. Signalling to heme oxygenase-1 and its anti-inflammatory therapeutic potential. Biochem Pharmacol 2010; 80: 1895-1903.
• 14 Newman PJ, Newman DK. Signal transduction pathways mediated by PECAM-1: new roles for an old molecule in platelet and vascular cell biology. Arterioscler Thromb Vasc Biol 2003; 23: 953-964.
• 15 Woodfin A, Voisin MB, Nourshargh S. PECAM-1: a multi-functional molecule in inflammation and vascular biology. Arterioscler Thromb Vasc Biol 2007; 27: 2514-2523.
• 16 Muller WA. Mechanisms of leukocyte transendothelial migration. Ann Rev Pathol 2011; 06: 323-344.
• 17 Privratsky JR, Newman DK, Newman PJ. PECAM-1: conflicts of interest in inflammation. Life Sci 2010; 87: 69-82.
• 18 Tzima E, Irani-Tehrani M, Kiosses WB. et al. A mechanosensory complex that mediates the endothelial cell response to fluid shear stress. Nature 2005; 437: 426-431.
• 19 Terry CM, Clikeman JA, Hoidal JR. et al. Effect of tumor necrosis factor-alpha and interleukin-1 alpha on heme oxygenase-1 expression in human endothelial cells. Am J Physiol 1998; 274: H883-891.
• 20 Rival Y, Del Maschio A, Rabiet MJ. et al. Inhibition of platelet endothelial cell adhesion molecule-1 synthesis and leukocyte transmigration in endothelial cells by the combined action of TNF-alpha and IFN-gamma. J Immunol 1996; 157: 1233-1241.
• 21 Stewart RJ, Kashour TS, Marsden PA. Vascular endothelial platelet endothelial adhesion molecule-1 (PECAM-1) expression is decreased by TNF-alpha, IFN-gamma. Evidence for cytokine-induced destabilisation of messenger ribonucleic acid transcripts in bovine endothelial cells. J Immunol 1996; 156: 1221-1228.
• 22 Liebl J, Weitensteiner SB, Vereb G. et al. Cyclin-dependent kinase 5 regulates en-dothelial cell migration and angiogenesis. J Biol Chem 2010; 285: 35932-35943.
• 23 Jaimes Y, Figueiredo C, Blasczyk R. Silencing the expression of platelet endothelial cell adhesion molecule-1 prevents allogeneic T-cell cytotoxicity. Transfusion 2010; 50: 1988-2000.
• 24 Santoso S, Sachs UJ, Kroll H. et al. The junctional adhesion molecule 3 (JAM-3) on human platelets is a counterreceptor for the leukocyte integrin Mac-1. J Exp Med 2002; 196: 679-691.
• 25 Kronke G, Bochkov VN, Huber J. et al. Oxidized phospholipids induce expression of human heme oxygenase-1 involving activation of cAMP-responsive element-binding protein. J Biol Chem 2003; 278: 51006-51014.
• 26 Alam J, Stewart D, Touchard C. et al. Nrf2, a Cap’n’Collar transcription factor, regulates induction of the heme oxygenase-1 gene. J Biol Chem 1999; 274: 26071-26078.
• 27 Hinkelmann U, Grosser N, Erdmann K. et al. Simvastatin-dependent up-regulation of heme oxygenase-1 via mRNA stabilisation in human endothelial cells. Eur J Pharm Sci 2010; 41: 118-124.
• 28 Sachs UJ, Andrei-Selmer CL, Maniar A. et al. The neutrophil-specific antigen CD177 is a counter-receptor for platelet endothelial cell adhesion molecule-1 (CD31). J Biol Chem 2007; 282: 23603-23612.
• 29 Rushworth SA, Chen XL, Mackman N. et al. Lipopolysaccharide-induced heme oxygenase-1 expression in human monocytic cells is mediated via Nrf2 and protein kinase C. J Immunol 2005; 175: 4408-4415.
• 30 Immenschuh S, Iwahara S-I, Satoh H. et al. Expression of the mRNA of heme-binding protein 23 is coordinated with that of heme oxygenase-1 by heme and heavy metals in primary rat hepatocytes and hepatoma cells. Biochemistry 1995; 34: 13407-13411.
• 31 Siow RCM, Ishii T, Sato H. et al. Induction of the antioxidant stress proteins heme oxygenase-1 and MSP23 by stress agents and oxidised LDL in cultured vascular smooth muscle cells. FEBS Lett 1995; 368: 239-242.
• 32 Kensler TW, Wakabayashi N, Biswal S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Ann Rev Pharmacol Toxicol 2007; 47: 89-116.
• 33 Wu CC, Hsieh CW, Lai PH. et al. Up-regulation of endothelial heme oxygenase-1 expression through the activation of the JNK pathway by sublethal concentrations of acrolein. Toxicol Appl Pharmacol 2006; 214: 244-252.
• 34 Wagener FA, Eggert A, Boerman OC. et al. Heme is a potent inducer of inflammation in mice and is counteracted by heme oxygenase. Blood 2001; 98: 1802-1811.
• 35 Jeney V, Balla J, Yachie A. et al. Pro-oxidant and cytotoxic effects of circulating heme. Blood 2002; 100: 879-887.
• 36 Wijayanti N, Kietzmann T, Immenschuh S. Heme oxygenase-1 gene activation by the NAD(P)H oxidase inhibitor 4-(2-aminoethyl) benzenesulfonyl fluoride via a protein kinase B, p38-dependent signalling pathway in monocytes. J Biol Chem 2005; 280: 21820-21829.
• 37 Nath KA, Balla G, Vercellotti GM. et al. Induction of heme oxygenase is a rapid, protective response in rhabdomyolysis in the rat. J Clin Invest 1992; 90: 267-270.
• 38 Bayat B, Werth S, Sachs UJ. et al. Neutrophil transmigration mediated by the neutrophil-specific antigen CD177 is influenced by the endothelial S536N dimorphism of platelet endothelial cell adhesion molecule-1. J Immunol 2010; 184: 3889-3896.
• 39 Kuckleburg CJ, Tilkens SB, Santoso S. et al. Proteinase 3 contributes to transendothelial migration of NB1-positive neutrophils. J Immunol 2012; 188: 2419-2426.
• 40 Immenschuh S, Baumgart-Vogt E, Tan M. et al. Differential cellular and subcellular localisation of heme-binding protein 23/peroxiredoxin I and heme oxygenase-1 in rat liver. J Histochem Cytochem 2003; 51: 1621-1631.
• 41 Kirino Y, Takeno M, Murakami S. et al. Tumor necrosis factor alpha acceleration of inflammatory responses by down-regulating heme oxygenase 1 in human peripheral monocytes. Arthritis Rheum 2007; 56: 464-475.
• 42 Kim YJ, Ahn JY, Liang P. et al. Human prx1 gene is a target of Nrf2 and is up-regulated by hypoxia/reoxygenation: implication to tumor biology. Cancer Res 2007; 67: 546-554.
• 43 Chen XL, Varner SE, Rao AS. et al. Laminar flow induction of antioxidant response element-mediated genes in endothelial cells. A novel anti-inflammatory mechanism. J Biol Chem 2003; 278: 703-711.
• 44 MacLeod AK, McMahon M, Plummer SM. et al. Characterisation of the cancer chemopreventive NRF2-dependent gene battery in human keratinocytes: demonstration that the KEAP1-NRF2 pathway, and not the BACH1-NRF2 pathway, controls cytoprotection against electrophiles as well as redox-cycling compounds. Carcinogenesis 2009; 30: 1571-1580.
• 45 Samoylenko A, Dimova EY, Horbach T. et al. Opposite expression of the antioxidant heme oxygenase-1 in primary cells and tumor cells: regulation by interaction of USF-2 and Fra-1. Antioxid Redox Signal 2008; 10: 1163-1174.
• 46 Alam J, Cook JL. How many transcription factors does it take to turn on the heme oxygenase-1 gene?. Am J Respir Cell Mol Biol 2007; 36: 166-174.
• 47 Naidu S, Wijayanti N, Santoso S. et al. An atypical NF-kappa B-regulated pathway mediates phorbol ester-dependent heme oxygenase-1 gene activation in monocytes. J Immunol 2008; 181: 4113-4123.
• 48 Cepinskas G, Savickiene J, Ionescu CV. et al. PMN transendothelial migration decreases nuclear NFkappaB in IL-1beta-activated endothelial cells: role of PECAM-1. J Cell Biol 2003; 161: 641-651.
• 49 Ruperez M, Rodrigues-Diez R, Blanco-Colio LM. et al. HMG-CoA reductase inhibitors decrease angiotensin II-induced vascular fibrosis: role of RhoA/ ROCK and MAPK pathways. Hypertension 2007; 50: 377-383.
• 50 Kietzmann T. Intracellular redox compartments: mechanisms and significances. Antioxid Redox Signal 2010; 13: 395-358.
• 51 Alom-Ruiz SP, Anilkumar N, Shah AM. Reactive oxygen species and endothelial activation. Antioxid Redox Signal 2008; 10: 1089-1100.
• 52 Madamanchi NR, Vendrov A, Runge MS. Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol 2005; 25: 29-38.
• 53 Koh KK, Oh PC, Quon MJ. Does reversal of oxidative stress and inflammation provide vascular protection?. Cardiovasc Res 2009; 81: 649-659.